Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
A ligand-centered framework for γδ T cell activation in colorectal cancer revealed by single-cell and transformer-based perturbation.
PMID 41607803 · PMC12835328 · Frontiers in immunology · 2025 · 8 claims · 8 setups
CRC-infiltrating γδ T cells show varied activation levels, with the TRM-like population being the major tumor-infiltrating subtype and exhibiting the lowest effector and exhaustion signature scores.
-
Has reproduction · 70
Bulk and single-cell characterisation of the immune heterogeneity of atherosclerosis identifies novel targets for immunotherapy.
PMID 36855107 · PMC9974063 · BMC biology · 2023 · 8 claims · 8 setups
Integration of scRNA-seq datasets from human atherosclerosis samples identifies 28 distinct immune cell subpopulations with heterogeneity in tissue preference, genetics, function, immune dynamics, transcriptional regulators, metabolism, and cell communication.
-
Full-text index only
A pan-cancer single cell landscape reveals heterogeneity and functional diversity of double-negative T cells.
PMID 41484771 · PMC12882460 · Molecular cancer · 2026 · 7 claims · 5 setups
Integration of pan-cancer scRNA-seq data yields a comprehensive single-cell atlas of 157,025 high-quality DNT cells across 23 cancer types.
-
Full-text index only
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma.
PMID 41644568 · PMC12982522 · Nature communications · 2026 · 8 claims · 6 setups
MM is not characterized by T cell exhaustion but by antigen-driven terminal memory differentiation, unlike solid cancers
-
Full-text index only
Immune profiling in a living human recipient of a gene-edited pig kidney.
PMID 41507576 · PMC12823403 · Nature medicine · 2026 · 8 claims · 8 setups
Xenograft experienced early T cell-mediated rejection (Banff grade 2A) within 1 week post-transplant despite profound circulating T cell depletion, likely driven by subtherapeutic immunosuppression and residual CD8+ T cells in lymph nodes.
-
Full-text index only
Atlas-guided discovery of transcription factors for T cell programming.
PMID 41639465 · PMC13017511 · Nature · 2026 · 8 claims · 8 setups
A multi-omics atlas (Taiji pipeline) integrating RNA-seq and ATAC-seq across nine CD8+ T cell states can predict TF activity and identify state-selective versus multi-state TFs
-
Has reproduction
Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets.
PMID 35672799 · PMC9175345 · Genome biology · 2022 · 8 claims · 7 setups
CD4+ T cells and B cells independently and significantly contribute to MS GWAS heritability enrichment, distinct from a merely shared immune regulatory landscape.
-
Full-text index only
Generation of thymus-reconstituting T cell progenitors from human pluripotent stem cells.
PMID 41512861 · PMC12853186 · Cell reports methods · 2026 · 7 claims · 6 setups
A cytokine-free hPSC hematopoietic differentiation protocol followed by OP9-DLL4 stromal co-culture generates pro-T cells without genetic manipulation
-
Full-text index only
Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy.
PMID 41680482 · PMC12920136 · Nature medicine · 2026 · 7 claims · 7 setups
Anti-PD-1 therapy triggers a rapid (within 24 hours) systemic cascade of increased IFN/antiviral, monocyte, and CD8+ T cell effector transcriptomic modules alongside decreased plasma TGFβ.
-
Full-text index only
Integrative bulk and single-cell transcriptomics link EZH2 to immunosuppressive programs and tumor-Treg crosstalk in castration-resistant prostate cancer.
PMID 41710887 · PMC12909565 · Frontiers in immunology · 2026 · 8 claims · 8 setups
Higher EZH2 expression is associated with adverse clinical outcomes in bulk PCa/CRPC cohorts